DK264785D0 - GALENIC RETARD PREPARATION - Google Patents

GALENIC RETARD PREPARATION

Info

Publication number
DK264785D0
DK264785D0 DK264785A DK264785A DK264785D0 DK 264785 D0 DK264785 D0 DK 264785D0 DK 264785 A DK264785 A DK 264785A DK 264785 A DK264785 A DK 264785A DK 264785 D0 DK264785 D0 DK 264785D0
Authority
DK
Denmark
Prior art keywords
galenic
retard preparation
retard
preparation
galenic retard
Prior art date
Application number
DK264785A
Other languages
Danish (da)
Other versions
DK167649B1 (en
DK264785A (en
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK264785D0 publication Critical patent/DK264785D0/en
Publication of DK264785A publication Critical patent/DK264785A/en
Application granted granted Critical
Publication of DK167649B1 publication Critical patent/DK167649B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK264785A 1984-06-14 1985-06-12 SOLID DISTRIBUTION WITH EXTENDED DELIVERY, SECONDARY STRUCTURE OF THE MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE DISPERSION OR STRUCTURE DK167649B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3422083 1984-06-14
DE3442566 1984-11-22
DE3442566 1984-11-22

Publications (3)

Publication Number Publication Date
DK264785D0 true DK264785D0 (en) 1985-06-12
DK264785A DK264785A (en) 1985-12-15
DK167649B1 DK167649B1 (en) 1993-12-06

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
DK264785A DK167649B1 (en) 1984-06-14 1985-06-12 SOLID DISTRIBUTION WITH EXTENDED DELIVERY, SECONDARY STRUCTURE OF THE MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE DISPERSION OR STRUCTURE

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
EP1189599A2 (en) * 1999-06-11 2002-03-27 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
JP3462490B2 (en) * 1999-08-04 2003-11-05 山之内製薬株式会社 Stable oral pharmaceutical composition
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
CA2434835A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
WO2008070118A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
MX2011001864A (en) * 2008-08-20 2011-06-20 Univ Texas Hot-melt extrusion of modified release multi-particulates.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
FI64938C (en) * 1977-06-20 1984-02-10 Sandoz Ag PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (en) * 1978-12-21 1989-06-05 Sandoz Ag PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
GB8727056D0 (en) 1987-12-23
SE8502950D0 (en) 1985-06-13
HU198844B (en) 1989-12-28
GB8514855D0 (en) 1985-07-17
FR2565822B1 (en) 1989-02-17
GB2196852A (en) 1988-05-11
BE902626A (en) 1985-12-10
NL194389B (en) 2001-11-01
NL194389C (en) 2002-03-04
PT80635A (en) 1985-07-01
ATA174885A (en) 1990-06-15
PT80635B (en) 1987-10-20
SE504583C2 (en) 1997-03-10
CA1264441A (en) 1990-01-16
LU85946A1 (en) 1986-01-24
GB2160100A (en) 1985-12-18
DE3520184C2 (en) 1997-03-13
GB2196852B (en) 1989-05-17
DK167649B1 (en) 1993-12-06
ES8702141A1 (en) 1987-01-01
HK25192A (en) 1992-04-10
DE3520184A1 (en) 1985-12-19
GB8727055D0 (en) 1987-12-23
DK264785A (en) 1985-12-15
IE851460L (en) 1985-12-14
AU4348685A (en) 1985-12-19
SE8502950L (en) 1985-12-15
GR851430B (en) 1985-11-25
GB2196851B (en) 1989-06-07
NZ212390A (en) 1992-02-25
CY1635A (en) 1992-11-06
IL75490A0 (en) 1985-10-31
IT8548210A0 (en) 1985-06-13
AT391806B (en) 1990-12-10
GB2196851A (en) 1988-05-11
GB2160100B (en) 1989-06-01
FR2565822A1 (en) 1985-12-20
IT1200080B (en) 1989-01-05
AU587190B2 (en) 1989-08-10
IE58834B1 (en) 1993-11-17
ES544075A0 (en) 1987-01-01
HUT40918A (en) 1987-03-30
NL8501578A (en) 1986-01-02
AU4454389A (en) 1990-03-22

Similar Documents

Publication Publication Date Title
DK264785D0 (en) GALENIC RETARD PREPARATION
DK60885D0 (en) ORAL PREPARATION
DK268285D0 (en) DIALCOXYPYRIDINE DERIVATIVES
DK35785A (en) TETRAHYDROCARBAZOLONE DERIVATIVES
DK243985A (en) AMINOALKYLPHENOXYDE DERIVATIVES
DE3463503D1 (en) SULFONAMIDO-BENZAMIDE DERIVATIVES
DE3566887D1 (en) FLAVANON DERIVATIVES
DK501085A (en) SUBSTITUTED BENZIMIDAZOLD DERIVATIVES
DK524585A (en) CHOLECALCIFERAL DERIVATIVES
DK460785D0 (en) SUBSTITUTED FURANGE DERIVATIVES
DK443685D0 (en) PIRIMIDINE DERIVATIVES
DK320585D0 (en) FLUORALLYLAMINE DERIVATIVES
DK333785A (en) mevalonolactone derivatives
DK201785A (en) TOPICAL PHARMACEUTICAL PREPARATION
DE3588103D1 (en) 5-fluorouracil derivatives
FI840579A0 (en) PIPETT MED REGLERBAR VOLYM
DK514585A (en) AMINOETHYLANILINE DERIVATIVES
DE3565100D1 (en) CYCLOALKANE-INDENE-CARBOXIMIDAMIDE DERIVATIVES
DK267190A (en) 13-substituted-5-ketomilbemycin derivatives
DK54085A (en) PHENYLPROPARGYLAMINE DERIVATIVES
DE3564269D1 (en) EBURNANE DERIVATIVES
ZA854520B (en) Novel galenic retard form
ES542485A0 (en) BORNANO DERIVATIVES PREPARATION PROCEDURE
SE8404468D0 (en) PHARMACEUTICAL PREPARATION
ATE46263T1 (en) THEOPHYLLINE RETARDED PREPARATION.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired